Century Therapeutics, Inc. (IPSC) stock
IPSCNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$1.65+0.02 (+1.23%)
Close on Nov 13, 2026Market cap $298.77MP/E –Yield –
Century Therapeutics enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Century Therapeutics's enterprise value was $194.44M on Nov 11, 2026, against -$88.72M a year earlier. Over the last 5 years it ranged from -$151.21M to $609.82M, with a median of -$14.80M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $194.44M | – |
| 2025 | Dec 31, 2025 | -$49.83M | – |
| 2024 | Dec 31, 2024 | -$115.55M | -542.7% |
| 2023 | Dec 29, 2023 | $26.10M | – |
| 2022 | Dec 30, 2022 | -$49.18M | -108.6% |
| 2021 | Dec 31, 2021 | $569.74M | – |
See a number that looks wrong?